Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Selective small-molecule inhibitors of CDK4 identified at Roche

July 15, 2003

AVP-893: a prototype of a novel class of antitumor agents designed at Avanir

July 15, 2003

Novel methionine aminopeptidase type 2 inhibitors discovered by GSK scientists

July 15, 2003

Optimization of CDK-2 inhibitor series as orally active antitumor agents

July 14, 2003

BMS presents second-generation farnesyltransferase inhibitors at AACR meeting

July 14, 2003

Ivax initiates phase II trial of talampanel for brain cancer

July 14, 2003

Enrollment completed for phase I/II study of 131I-TM-601 in glioma

July 14, 2003

Promising activity reported for Nipent combination therapy in NHL

July 14, 2003

New antiproliferative agents in Sankyo development pipeline

July 14, 2003

Cytotoxic macrolactones discovered at GBF assumed to act by inhibiting V-ATPase

July 14, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
Circulating sncRNA transcriptome in diabetic kidney disease and SGLT2 inhibitor treatment
BioWorld Science
Small noncoding RNAs (sncRNAs), including miRNAs, piRNAs and snoRNAs, can provide further biological insights into the mechanisms of chronic kidney disease (CKD)...